Terumo (OTCMKTS:TRUMY) Shares Gap Up – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMY) shares gapped up before the market opened on Monday . The stock had previously closed at $12.18, but opened at $14.04. Terumo shares last traded at $14.4386, with a volume of 24,330 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on TRUMY shares. Zacks Research raised shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Nomura raised shares of Terumo to a “hold” rating in a research report on Tuesday, February 24th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Terumo Stock Down 0.1%

The company has a market cap of $21.20 billion, a P/E ratio of 23.56 and a beta of 0.62. The stock’s 50-day moving average price is $13.15 and its 200-day moving average price is $13.95. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings data on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.11. The company had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.35%. As a group, research analysts forecast that Terumo Corp. will post 0.63 EPS for the current year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.